Skip to content

Investigating the effectiveness of tDCS on pain and neuro-cognitive parameters in women with non-specific chronic low back pain

Investigating the effectiveness of transcranial direct current stimulation (tDCS) over the dorsolateral prefrontal cortex on pain and neurocognitive parameters in women with non-specific chronic low back pain

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240108060653N1
Enrollment
30
Registered
2024-04-12
Start date
2024-02-02
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non specific chronic low back pain. Non-specific chronic low back pain

Interventions

Intervention 1: Intervention group will receive active tDCS with an intensity of 2 milliamps for 5 sessions every other day, each session including two 20-minute stages with a 20-minute interval betwe

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Being female Age range 18-45 years The pain is mainly felt in the back in the range of the lower side of the 12th rib to the bottom of the gluteal fold in the back and there are no signs of radicular pain Persistent pain (more than three days per week) and at least 3 months since the onset of pain and a pain intensity of 4 or greater on the Visual Analogue Pain Scale being right-handed Being literate in reading and writing (at least a diploma) The pain is mainly felt in the back in the range of the lower side of the 12th rib to the bottom of the gluteal fold in the back and there are no signs of radicular pain. There is persistent pain (more than three days a week) and it has been at least 3 months since the onset of this pain, and the pain intensity is 4 or more on the pain visual analogue scale (VAS). being right-handed

Exclusion criteria

Exclusion criteria: Infection, spinal tumor, cancer and acute trauma such as fracture in the last 6 months and the presence of deformity in the spine or lower limbs such as scoliosis or kyphosis History of spinal surgery, lower limb or abdominal surgery in less than 6 months Metal devices implanted in the brain and pacemakers A history of seizures or the use of drugs to reduce the seizure threshold being pregnant The patient has received active treatment in the last 3 months or routinely takes painkillers and any drugs affecting cognitive function Vision and hearing problems that cannot be corrected Scratches and cuts in the scalp area or skin infection Skin or joint problems (rheumatic diseases) History of traumatic brain injury or neurosurgery and neurological abnormalities in the central nervous system Disorder or lack of sensation in the scalp area

Design outcomes

Primary

MeasureTime frame
Pain visual analogue scale score. Timepoint: Before intervention, after the first session of intervention, after the fifth session of intervention, one month after the last session. Method of measurement: 100 millimeters visual analog pain scale ruler.;Visual choice reaction time. Timepoint: Before the start of the intervention, after the first session of the intervention, after the fifth session of the intervention, one month after the last session of the intervention. Method of measurement: SART system.;Visual choice reaction time. Timepoint: Before the start of the intervention, after the first session of the intervention, after the fifth session of the intervention, one month after the last session of the intervention. Method of measurement: SART system.;Auditory choice reaction time. Timepoint: Before the start of the intervention, after the first session of the intervention, after the fifth session of the intervention, one month after the last session of the intervention. Method of measurement: SART system.;Auditory complex choice reaction time. Timepoint: Before the start of the intervention, after the first session of the intervention, after the fifth session of the intervention, one month after the last session of the intervention. Method of measurement: SART system.;Anticipation skill with low speed. Timepoint: Before the start of the intervention, after the first session of the intervention, after the fifth session of the intervention, one month after the last session of the intervention. Method of measurement: SART system.;Anticipation skill with high speed. Timepoint: Before the start of the intervention, after the first session of the intervention, after the fifth session of the intervention, one month after the last session of the intervention. Method of measurement: SART system.

Secondary

MeasureTime frame
Pressure Pain Threshold of myotome. Timepoint: Before the intervention, after the first intervention session, after the fifth intervention session and one month after the last intervention session. Method of measurement: Using pressure algometer.;Score of depression, anxiety and stress. Timepoint: before the start of the intervention, after the fifth session of the intervention and one month after the last session of the intervention. Method of measurement: Depression, anxiety and stress scale (DASS-21).;Quality of life score. Timepoint: ?efore the start of the intervention, after the fifth session of the intervention and one month after the last session of the intervention. Method of measurement: European quality of life questionnaire (5D-3L).;Physical disability score. Timepoint: Before the start of the intervention, after the fifth session of the intervention, one month after the last session of the intervention. Method of measurement: Roland and Morris disability questionnaire.;Pressure pain threshold of sclerotome. Timepoint: Before the intervention, after the first intervention session, after the fifth intervention session and one month after the last intervention session. Method of measurement: Pressure algometer.;Pressure pain threshold of dermatome. Timepoint: Before the intervention, after the first intervention session, after the fifth intervention session and one month after the last intervention session. Method of measurement: Pressure algometer.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHaniyeh Danehkar

Tehran University of Medical Sciences

h-danehkar@razi.tums.ac.ir+98 21 7752 8468

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026